B. Knihy a kapitoly v knihách
12. ŠAREK, J. – KVASNICA, M. – VLK, M. – URBAN, M. – DZUBAK, P. – HAJDUCH, M. The Potential of Triterpenoids in the Treatment of Melanoma. In Research on Melanoma – A Glimpse into Current Directions and Future Trends (InTech). 1.vyd. Rijeka, 2011. Kapitola 7, s. 125-158. ISBN: 978-953-307-293-7
11. SCHWARZ, D. – KLIMEŠ, D. – DUŠEK, L. – HAJDÚCH, M. – BRABEC, P. – ŠTÍPEK, S. – ŠTUKA, Č. – MIHÁL, V. eHealth Principles and thein Implementation in Czech Cancer Care. In CZECH CANCER CARE In NUMBERS 2008-2009 (Grada Publishing). 1.vyd. Praha, 2009. Kapitola 15, s. 377-389. ISBN: 978-80-247-3244-2
DEDIKACE KNIHY: Czech Medical Association of Jan Evangelista Purkyne (CzMA) on the basis of a research grant from the company AstraZeneca Czech Republic, Ltd. (the project „National Cancer Control Programme On-line“); the data processing was supported by research grants from IGA MZCR 10621-2 a 10650-3.
DEDIKACE KAPITOLY č.15: The MEFANET project (MEdical FAculties Network) has been supported by a research grant from the Czech Ministry of Education, Youth and Sports (grant No. C15/2009: Educational network of medici faculties for developing and sparing digital content on a common platform). The development and maintenance of the national electronic library of CHT regiment and associatedreporting tools have been supported by a long.term research grant from Amge, Inc.
10. HAJDÚCH, M. – SKALNÍKOVÁ, H. – HALADA, P. – VYDRA, D. – DŽUBÁK, P. – DZIECHCIARKOVÁ, M. – STRNAD, M. – RADZIOCH, D. – GADHER, S.J. – KOVÁŘOVÁ, H. Cyclin-Dependent Kinase Inhibitors and Cancer: Usefulness of Proteomic Approaches in Assesment of the Molecular mechanisms and Efficacy of Novel Therapeutics.. In Clinical Proteomics (J.Van Eyk and M.Dunn, eds.). 1.vyd. Winheim: Wiley-VCH Verlag GmbH & Co, 2008. Kapitola 13, s. 177-202. ISBN: 978-3-527-31637-3
9. HAJDÚCH, M. – TROJANEC, R. – NOSKOVÁ, V. – DŽUBÁK, P. – KOLÁŘ, Z. – ŠPAČKOVÁ, K. – ŠKARDA, J. – DUŠEK, L. – BOUCHAL, J. – VYDRA, D. – CWIERTKA, K. – ŽALOUDÍK, J. – MIHÁL, V. Racionální individualizace protinádorové léčby – molekulární, buněčné a klinické aspekty. In Edukační sborník. 2003. s.136-147.
ISBN: 80-239-0175-3
8. DUŠEK, L. – ŠTĚRBA, J. – REGNER, B. – MIHÁL, V. – MALIŠ, J. – ŠMELHAUS, V. – HAJDÚCH, M. – ECKSCHLAGER, T. – BLAŽEK, B. – KOSTÍKOVÁ, J. – KEPÁK, T. – STARÝ, J. – POUTECKÝM, J. Epidemiologická a klinická registrace odpovídající potřebám současné onkologie - modelová studie nádorů dětského věku Management a analýza klinických dat. Autoreferát. In Edukační sborník. 2002. vol. 26, s. 82-86
7. HAJDÚCH, M. - MICHÁLEK, J. - PAPAJÍK, T. - ŠTĚRBA, J. - TALAČ, R. - VYZULA, R. - ŽALOUDÍK, J. Monoclonal antibodies in oncology. (in Czech). In Mediforum, Maxdorf s.r.o. Praha: 2000. Kapitola: 1, s. 10-22.
ISBN: 80-85912-42-2
6. MIHÁL, V. – HAJDÚCH, M. - JAROŠOVÁ, M. Pharmacogenetic classification of cancer patients? In Diagnostics and therapy in paediatrics IV (in Slovak). Osveta, Martin: 1998. s.31-37.
5. MIHÁL, V. – HAJDÚCH, M. - NOSKOVÁ, V. - FEKETOVÁ, G. - JESS, K. - GOJOVÁ, L. - KAŠPÁREK, I. - STARÝ, J. - BLAŽEK, B. Differential antileukemic activity of prednisolone and dexamethasone in freshly isolated leukemic cells. In: Pieters, R., Veerman, A., Kaspers, GJL (Eds.): Drug Resistance in Leukaemia and Lymphoma, In Advances in Experimental Medicine and Biology. New York: Kluwer Academic/Plenum Press, 1999. s. 461-471.
4. HAJDÚCH, M. - HAVLIČEK, L. - VESELÝ, J. - NOVOTNÝ, R. - MIHÁL, V. – STRNAD, M. Synthetic cyclin dependent kinase inhibitors - New generation of potent anti-cancer drugs. In: Pieters, R., Veerman, A., Kaspers, GJL (Eds.): Drug Resistance in Leukaemia and Lymphoma, In Advances in Experimental Medicine and Biology. New York: Kluwer Academic/Plenum Press, 1999, s. 341-353.
3. BÁRTOVÁ, A. - AMBRUZOVÁ, Z. - PETŘEK, M. - SLAVÍKOVÁ, E. - SZABOVÁ, K. – HAJDÚCH, M. - ANTÁLEK, P. - MIHÁL, V. - WEIGL, E. Czech Population, In HLA 1997 - An HLA reference book based on DNA typing (Eds. Terasaki P.I., Gjertson, D.W.,). University of Kalifornia, Los Angeles: 1998. s. 1-5.
2. MIHÁL, V. – HAJDÚCH, M. - ŠAFÁŘOVÁ, M. What is the prognostic value of in vitro drug resistance assay in childhood ALL in short-term clinical outcome? In Diagnostics and therapy in paediatrics III (in Slovak). Osveta, Martin: 1997.
1. MIHÁL, V. - POSPÍŠILOVÁ, D. – HAJDÚCH, M. Application of cytokines in paediatric practice, In Diagnostics and therapy in paediatrics II (in Slovak), Osveta Martin: 1995. s.34-40.